Latest Strategic Investment News

Comms Group Limited reported a steady 2% revenue increase in FY25, hitting the highest gross margin in five years, while targeting over $75 million in run-rate revenue post-TasmaNet integration.

Charger Metals has initiated a 3,000m drilling program at its Lake Johnston Lithium and Gold Project, fully funded by Rio Tinto Exploration, targeting multiple high-priority lithium and gold prospects. This follows a recent maiden resource estimate and aims to unlock further potential in a prolific Western Australian region.

Veris Limited has reversed its FY24 loss to post a $2.0 million profit before tax in FY25, driven by digital growth and strategic acquisitions. The company’s focus on higher-margin consulting and advisory services underpins a positive outlook for FY26.

South Harz Potash Limited is progressing its transition to a dual-asset strategy, raising A$2.58 million to support expansion while adopting a cautious approach to its core German potash project amid market weakness.

Pure Hydrogen Corporation has locked in a $2.5 million loan facility to accelerate its clean energy vehicle rollout, aiming to capitalise on a growing sales pipeline in Australia and the US.

Plenti Group Limited has reported a fourth straight quarter of record loan originations, driving a 24% annual growth in its loan portfolio and doubling its half-year profits. The fintech lender is accelerating towards a $3 billion loan book target by March 2026 amid strong credit performance and strategic investments.

Stanmore Resources delivered record coal production in Q3 2025, driven by strong operational execution at South Walker Creek and Poitrel, while adjusting full-year guidance to reflect site-specific challenges and market conditions.

Qoria Limited reported a strong start to FY2026, with annual recurring revenue climbing 25% year-on-year and record cash receipts of $46.3 million, prompting an upgrade to its full-year revenue guidance.

Resolution Minerals secures a $2 million placement from Tribeca Investment Partners, reinforcing its position in the U.S. critical minerals sector and advancing exploration at the strategically important Horse Heaven Project.

Orthocell has boosted its investment in Marine Biomedical to secure exclusive global distribution rights for PearlBone™, an innovative bone substitute nearing FDA approval, enhancing its regenerative medicine portfolio.

Botanix Pharmaceuticals reports a strong start to FY26 with a 50% surge in Sofdra prescriptions and a 65% rise in net revenue, underpinned by a larger sales team and operational efficiencies.

Iluka Resources reported steady Q3 production but announced suspension of synthetic rutile and Cataby mine operations from December 2025, aiming for significant cost savings. Meanwhile, rare earths refinery construction accelerates amid tightening Chinese export controls.